Influence of the NR3A subunit on NMDA receptor functions

Progress in Neurobiology

Volumn 91, Issue 1, 2010, Pages 23-37

  Henson, Maile A ^a   Roberts, Adam C ^a   Pérez Otaño, Isabel ^b   Philpot, Benjamin D ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Dendritic spine; LTP; Neurodevelopmental disorders; NMDA receptor; NMDA subunit; NR3A; Synapse elimination; Synapse maturation; Synaptic plasticity

Indexed keywords

CALCIUM ION; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GLYCINE; GLYCINE RECEPTOR; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 3A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; BRAIN INJURY; BRAIN REGION; CELLULAR DISTRIBUTION; DRUG TARGETING; EPILEPSY; EXCITOTOXICITY; HUMAN; HUNTINGTON CHOREA; HYPERPOLARIZATION; MEMBRANE CONDUCTANCE; MEMBRANE PERMEABILITY; MENTAL DEFICIENCY; NERVE CELL MEMBRANE POTENTIAL; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; ONTOGENY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW; SCHIZOPHRENIA; SPECIES DIFFERENCE; STROKE; TRAUMATIC BRAIN INJURY;

AMINO ACID SEQUENCE; ANIMALS; BRAIN; EXCITATORY AMINO ACID AGONISTS; HUMANS; NERVOUS SYSTEM DISEASES; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; RECEPTORS, GLUTAMATE; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE; TISSUE DISTRIBUTION;

EID: 77952954220     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2010.01.004     Document Type: Review

References (189)

1. Abdrachmanova G., Teisinger J., Vyklicky L. Axotomy-induced changes in the properties of NMDA receptor channels in rat spinal cord motoneurons. J. Physiol. 2002, 538:53-63.
2. Akbarian S., Sucher N.J., Bradley D., Tafazzoli A., Trinh D., Hetrick W.P., Potkin S.G., Sandman C.A., Bunney W.E., Jones E.G. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J. Neurosci. 1996, 16:19-30.
3. Al-Hallaq R.A., Jarabek B.R., Fu Z., Vicini S., Wolfe B.B., Yasuda R.P. Association of NR3A with the N-methyl-d-aspartate receptor NR1 and NR2 subunits. Mol. Pharmacol. 2002, 62:1119-1127.
4. Andersson O., Stenqvist A., Attersand A., von Euler G. Nucleotide sequence, genomic organization, and chromosomal localization of genes encoding the human NMDA receptor subunits NR3A and NR3B. Genomics 2001, 78:178-184.
5. Arundine M., Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell. Mol. Life Sci. 2004, 61:657-668.
6. Atlason P.T., Garside M.L., Meddows E., Whiting P., McIlhinney R.A. N-Methyl-d-aspartate (NMDA) receptor subunit NR1 forms the substrate for oligomeric assembly of the NMDA receptor. J. Biol. Chem. 2007, 282:25299-25307.
7. Awobuluyi M., Yang J., Ye Y., Chatterton J.E., Godzik A., Lipton S.A., Zhang D. Subunit-specific roles of glycine-binding domains in activation of NR1/NR3 N-methyl-d-aspartate receptors. Mol. Pharmacol. 2007, 71:112-122.
8. Bear, M.F., 1996. A synaptic basis for memory storage in the cerebral cortex. Proc. Natl. Acad. Sci. U.S.A.
9. Bellinger D., Sloman J., Leviton A., Rabinowitz M., Needleman H.L., Waternaux C. Low-level lead exposure and children's cognitive function in the preschool years. Pediatrics 1991, 87:219-227.
10. Bendel O., Meijer B., Hurd Y., von Euler G. Cloning and expression of the human NMDA receptor subunit NR3B in the adult human hippocampus. Neurosci. Lett. 2005, 377:31-36.
11. Bendova Z., Sumova A., Mikkelsen J.D. Circadian and developmental regulation of N-methyl-d-aspartate-receptor 1 mRNA splice variants and N-methyl-d-aspartate-receptor 3 subunit expression within the rat suprachiasmatic nucleus. Neuroscience 2009, 159:599-609.
12. Bliss T.V.P., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
13. Bonuccelli U., Del Dotto P. New pharmacologic horizons in the treatment of Parkinson disease. Neurology 2006, 67:S30-38.
14. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 2001, 156:234-258.
15. Brody S.A., Nakanishi N., Tu S., Lipton S.A., Geyer M.A. A developmental influence of the N-methyl-d-aspartate receptor NR3A subunit on prepulse inhibition of startle. Biol. Psychiatry 2005, 57:1147-1152.
16. Carlisle H.J., Kennedy M.B. Spine architecture and synaptic plasticity. Trends Neurosci. 2005, 28:182-187.
17. Cavara N.A., Hollmann M. Shuffling the deck anew: how NR3 tweaks NMDA receptor function. Mol. Neurobiol. 2008, 38:16-26.
18. Chan S.F., Sucher N.J. An NMDA receptor signaling complex with protein phosphatase 2A. J. Neurosci. 2001, 21:7985-7992.
19. Chatterton J.E., Awobuluyi M., Premkumar L.S., Takahashi H., Talantova M., Shin Y., Cui J., Tu S., Sevarino K.A., Nakanishi N., Tong G., Lipton S.A., Zhang D. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 2002, 415:793-798.
20. Chazot P.L., Cik M., Stephenson F.A. An investigation into the role of N-glycosylation in the functional expression of a recombinant heteromeric NMDA receptor. Mol. Membr. Biol. 1995, 12:331-337.
21. Chechlacz M., Gleeson J.G. Is mental retardation a defect of synapse structure and function?. Pediatr. Neurol. 2003, 29:11-17.
22. Chen B.S., Roche K.W. Regulation of NMDA receptors by phosphorylation. Neuropharmacology 2007, 53:362-368.
23. Choi D.W. Excitotoxic cell death. J. Neurobiol. 1992, 23:1261-1276.
24. Chowdari K.V., Mirnics K., Semwal P., Wood J., Lawrence E., Bhatia T., Deshpande S.N., B K.T., Ferrell R.E., Middleton F.A., Devlin B., Levitt P., Lewis D.A., Nimgaonkar V.L. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum. Mol. Genet. 2002, 11:1373-1380.
25. Ciabarra A.M., Sevarino K.A. An anti-chi-1 antibody recognizes a heavily glycosylated protein in rat brain. Brain Res. Mol. Brain Res. 1997, 46:85-90.
26. Ciabarra A.M., Sullivan J.M., Gahn L.G., Pecht G., Heinemann S., Sevarino K.A. Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J. Neurosci. 1995, 15:6498-6508.
27. Constantine-Paton M., Cline H.T., Debski E. Patterned activity, synaptic convergence, and the NMDA receptor in developing visual pathways. Annu. Rev. Neurosci. 1990, 13:129-154.
28. Covarrubias M., Kopta C., Steinbach J.H. Inhibitors of asparagine-linked oligosaccharide processing alter the kinetics of the nicotinic acetylcholine receptor. J. Gen. Physiol. 1989, 93:765-783.
29. Coyle J.T., Tsai G., Goff D. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann. N. Y. Acad. Sci. 2003, 1003:318-327.
30. Coyle J.T., Yamamura H.I. Neurochemical aspects of the ontogenesis of cholinergic neurons in the rat brain. Brain Res. 1976, 118:429-440.
31. Crews F.T., Steck J.C., Chandler L.J., Yu C.J., Day A. Ethanol, stroke, brain damage, and excitotoxicity. Pharmacol. Biochem. Behav. 1998, 59:981-991.
32. Cull-Candy S., Brickley S., Farrant M. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 2001, 11:327-335.
33. Cull-Candy S.G., Leszkiewicz D.N. Role of distinct NMDA receptor subtypes at central synapses. Sci. STKE 2004, 2004:re16.
34. Das S., Sasaki Y.F., Rothe T., Premkumar L.S., Takasu M., Crandall J.E., Dikkes P., Conner D.A., Rayudu P.V., Cheung W., Chen H.S., Lipton S.A., Nakanishi N. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 1998, 393:377-381.
35. de Graaf-Peters V.B., Hadders-Algra M. Ontogeny of the human central nervous system: what is happening when?. Early Hum. Dev. 2006, 82:257-266.
36. Dubner R., Ruda M.A. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 1992, 15:96-103.
37. Dunah A.W., Yasuda R.P., Wang Y.H., Luo J., Davila-Garcia M., Gbadegesin M., Vicini S., Wolfe B.B. Regional and ontogenic expression of the NMDA receptor subunit NR2D protein in rat brain using a subunit-specific antibody. J. Neurochem. 1996, 67:2335-2345.
38. Durand G.M., Bennett M.V., Zukin R.S. Splice variants of the N-methyl-d-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C. [published erratum appears in Proc Natl Acad Sci U S A 1993 Oct 15;90(20):9739]. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:6731-6735.
39. Durand G.M., Gregor P., Zheng X., Bennett M.V., Uhl G.R., Zukin R.S. Cloning of an apparent splice variant of the rat N-methyl-d-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:9359-9363.
40. Emamian E.S., Karayiorgou M., Gogos J.A. Decreased phosphorylation of NMDA receptor type 1 at serine 897 in brains of patients with Schizophrenia. J. Neurosci. 2004, 24:1561-1564.
41. Engert F., Bonhoeffer T. Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature 1999, 399:66-70.
42. Eriksson M., Nilsson A., Froelich-Fabre S., Akesson E., Dunker J., Seiger A., Folkesson R., Benedikz E., Sundstrom E. Cloning and expression of the human N-methyl-d-aspartate receptor subunit NR3A. Neurosci. Lett. 2002, 321:177-181.
43. Eriksson M., Nilsson A., Samuelsson H., Samuelsson E.B., Mo L., Akesson E., Benedikz E., Sundstrom E. On the role of NR3A in human NMDA receptors. Physiol. Behav. 2007, 92:54-59.
44. Eriksson M., Samuelsson H., Samuelsson E.B., Liu L., McKeehan W.L., Benedikz E., Sundstrom E. The NMDAR subunit NR3A interacts with microtubule-associated protein 1S in the brain. Biochem. Biophys. Res. Commun. 2007, 361:127-132.
45. Fan M.M., Raymond L.A. N-methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Prog. Neurobiol. 2007, 81:272-293.
46. Fellous J.M., Sejnowski T.J. Regulation of persistent activity by background inhibition in an in vitro model of a cortical microcircuit. Cereb. Cortex 2003, 13:1232-1241.
47. Fiala J.C., Spacek J., Harris K.M. Dendritic spine pathology: cause or consequence of neurological disorders?. Brain Res. Brain Res. Rev. 2002, 39:29-54.
48. Fujikawa D.G. Prolonged seizures and cellular injury: understanding the connection. Epilepsy Behav. 2005, 7(Suppl. 3):S3-S11.
49. Fukaya M., Hayashi Y., Watanabe M. NR2 to NR3B subunit switchover of NMDA receptors in early postnatal motoneurons. Eur. J. Neurosci. 2005, 21:1432-1436.
50. Furukawa H., Singh S.K., Mancusso R., Gouaux E. Subunit arrangement and function in NMDA receptors. Nature 2005, 438:185-192.
51. Gallinat J., Gotz T., Kalus P., Bajbouj M., Sander T., Winterer G. Genetic variations of the NR3A subunit of the NMDA receptor modulate prefrontal cerebral activity in humans. J. Cogn. Neurosci. 2007, 19:59-68.
52. Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 2000, 57:65-73.
53. Glantz L.A., Lewis D.A. Dendritic spine density in schizophrenia and depression. Arch. Gen. Psychiatry 2001, 58:203.
54. Goebel D.J., Poosch M.S. NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A. Brain Res. Mol. Brain Res. 1999, 69:164-170.
55. Goff D.C., Tsai G., Levitt J., Amico E., Manoach D., Schoenfeld D.A., Hayden D.L., McCarley R., Coyle J.T. A placebo-controlled trial of d-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch. Gen. Psychiatry 1999, 56:21-27.
56. Goff D.C., Tsai G., Manoach D.S., Coyle J.T. Dose-finding trial of d-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am. J. Psychiatry 1995, 152:1213-1215.
57. Groc L., Heine M., Cousins S.L., Stephenson F.A., Lounis B., Cognet L., Choquet D. NMDA receptor surface mobility depends on NR2A-2B subunits. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:18769-18774.
58. Gu Z., Jiang Q., Fu A.K., Ip N.Y., Yan Z. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J. Neurosci. 2005, 25:4974-4984.
59. Gustafsson B., Wigstrom H. Physiological mechanisms underlying long-term potentiation. Trends Neurosci. 1988, 11:156-162.
60. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 2005, 10:40-68. image 45.
61. Hatton C.J., Paoletti P. Modulation of triheteromeric NMDA receptors by N-terminal domain ligands. Neuron 2005, 46:261-274.
62. Henson M.A., Roberts A.C., Salimi K., Vadlamudi S., Hamer R.M., Gilmore J.H., Jarskog L.F., Philpot B.D. Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex. Cereb. Cortex 2008, 18:2560-2573.
63. Heresco-Levy U., Javitt D.C., Ermilov M., Mordel C., Horowitz A., Kelly D. Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia. Br. J. Psychiatry 1996, 169:610-617.
64. Heresco-Levy U., Javitt D.C., Ermilov M., Silipo G., Shimoni J. Double-blind, placebo-controlled, crossover trial of d-cycloserine adjuvant therapy for treatment-resistant schizophrenia. Int. J. Neuropsychopharmcol. 1998, 1:131-135.
65. Hirai H., Kirsch J., Laube B., Betz H., Kuhse J. The glycine binding site of the N-methyl-d-aspartate receptor subunit NR1: identification of novel determinants of co-agonist potentiation in the extracellular M3-M4 loop region. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:6031-6036.
66. Hirai T., Yoneda Y. Functional alterations in immature cultured rat hippocampal neurons after sustained exposure to static magnetic fields. J. Neurosci. Res. 2004, 75:230-240.
67. Hollmann M., Boulter J., Maron C., Beasley L., Sullivan J., Pecht G., Heinemann S. Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor. Neuron 1993, 10:943-954.
68. Hoyte L., Barber P.A., Buchan A.M., Hill M.D. The rise and fall of NMDA antagonists for ischemic stroke. Curr. Mol. Med. 2004, 4:131-136.
69. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vockler J., Dikranian K., Tenkova T.I., Stefovska V., Turski L., Olney J.W. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999, 283:70-74.
70. Irwin S.A., Swain R.A., Christmon C.A., Chakravarti A., Weiler I.J., Greenough W.T. Evidence for altered Fragile-X mental retardation protein expression in response to behavioral stimulation. Neurobiol. Learn. Mem. 2000, 74:87-93.
71. Isaac J.T.R., Nicoll R.A., Malenka R.C. Evidence for silent synapses: implications for the expression of LTP and LTD. Neuron 1995, 15:427-434.
72. Ishihama K., Kogo M., Wakisaka S., Turman J.E. Prenatal development of NMDA receptor composition and function in trigeminal neurons. Arch. Histol. Cytol. 2005, 68:321-335.
73. Ishihama K., Turman J.E. NR3 protein expression in trigeminal neurons during postnatal development. Brain Res. 2006, 1095:12-16.
74. Javitt D.C. Glycine modulators in schizophrenia. Curr. Opin. Investig. Drugs 2002, 3:1067-1072.
75. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 1991, 148:1301-1308.
76. Javitt D.C., Zylberman I., Zukin S.R., Heresco-Levy U., Lindenmayer J.P. Amelioration of negative symptoms in schizophrenia by glycine. Am. J. Psychiatry 1994, 151:1234-1236.
77. Karadottir R., Cavelier P., Bergersen L.H., Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005, 438:1162-1166.
78. Kaufmann W.E., Moser H.W. Dendritic anomalies in disorders associated with mental retardation. Cereb. Cortex 2000, 10:981-991.
79. Kennedy M.B., Beale H.C., Carlisle H.J., Washburn L.R. Integration of biochemical signalling in spines. Nat. Rev. Neurosci. 2005, 6:423-434.
80. Kleckner N.W., Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science 1988, 241:835-837.
81. Kohr G. NMDA receptor function: subunit composition versus spatial distribution. Cell Tissue Res. 2006, 326:439-446.
82. Kuner T., Wollmuth L.P., Karlin A., Seeburg P.H., Sakmann B. Structure of the NMDA receptor channel M2 segment inferred from the accessibility of substituted cysteines. Neuron 1996, 17:343-352.
83. Lau C.G., Zukin R.S. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat. Rev. Neurosci. 2007, 8:413-426.
84. Laube B., Kuhse J., Betz H. Evidence for a tetrameric structure of recombinant NMDA receptors. J. Neurosci. 1998, 18:2954-2961.
85. Laurie D.J., Bartke I., Schoepfer R., Naujoks K., Seeburg P.H. Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies. Brain Res. Mol. Brain Res. 1997, 51:23-32.
86. Laurie D.J., Seeburg P.H. Ligand affinities at recombinant N-methyl-d-aspartate receptors depend on subunit composition. Eur. J. Pharmacol. 1994, 268:335-345.
87. Lavezzari G., McCallum J., Dewey C.M., Roche K.W. Subunit-specific regulation of NMDA receptor endocytosis. J. Neurosci. 2004, 24:6383-6391.
88. Li Y.H., Han T.Z. Glycine binding sites of presynaptic NMDA receptors may tonically regulate glutamate release in the rat visual cortex. J. Neurophysiol. 2006.
89. Liao D., Hessler N.A., Malinow R. Activation of postsynaptically silent synapses during pairing-induced LTP in CA1 region of hippocampal slice. Nature 1995, 375:400-404.
90. Lipton S.A. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat. Rev. Drug Discov. 2006, 5:160-170.
91. Lipton S.A., Nakanishi N. Shakespeare in love-with NMDA receptors?. Nat. Med. 1999, 5:270-271.
92. Lisman J. A mechanism for the Hebb and the anti-Hebb processes underlying learning and memory. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:9574-9578.
93. Lovinger D.M. Excitotoxicity and alcohol-related brain damage. Alcohol Clin. Exp. Res. 1993, 17:19-27.
94. Lujan R., Shigemoto R., Lopez-Bendito G. Glutamate and GABA receptor signalling in the developing brain. Neuroscience 2005, 130:567-580.
95. Ma O.K., Sucher N.J. Molecular interaction of NMDA receptor subunit NR3A with protein phosphatase 2A. Neuroreport 2004, 15:1447-1450.
96. Madison D.V., Malenka R.C., Nicoll R.A. Mechanisms underlying long-term potentiation of synaptic transmission. Annu. Rev. Neurosci. 1991, 14:379-397.
97. Madry C., Mesic I., Bartholomaus I., Nicke A., Betz H., Laube B. Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function. Biochem. Biophys. Res. Commun. 2007, 354:102-108.
98. Malenka R.C., Bear M.F. LTP and LTD: an embarrassment of riches. Neuron 2004, 44:5-21.
99. Maletic-Savatic M., Malinow R., Svoboda K. Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity. Science 1999, 283:1923-1927.
100. Martin L.J., Al-Abdulla N.A., Brambrink A.M., Kirsch J.R., Sieber F.E., Portera-Cailliau C. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res. Bull. 1998, 46:281-309.
101. Martucci L., Wong A.H., Trakalo J., Cate-Carter T., Wong G.W., Macciardi F.M., Kennedy J.L. N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia: TDT and case-control analyses. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003, 119:24-27.
102. Matsuda K., Fletcher M., Kamiya Y., Yuzaki M. Specific assembly with the NMDA receptor 3B subunit controls surface expression and calcium permeability of NMDA receptors. J. Neurosci. 2003, 23:10064-10073.
103. Matsuda K., Kamiya Y., Matsuda S., Yuzaki M. Cloning and characterization of a novel NMDA receptor subunit NR3B: a dominant subunit that reduces calcium permeability. Brain Res. Mol. Brain Res. 2002, 100:43-52.
104. Matute C. Oligodendrocyte NMDA receptors: a novel therapeutic target. Trends Mol. Med. 2006, 12:289-292.
105. Matute C., Alberdi E., Domercq M., Sanchez-Gomez M.V., Perez-Samartin A., Rodriguez-Antiguedad A., Perez-Cerda F. Excitotoxic damage to white matter. J. Anat. 2007, 210:693-702.
106. Matute C., Sanchez-Gomez M.V., Martinez-Millan L., Miledi R. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:8830-8835.
107. McBain C.J., Mayer M.L. N-methyl-d-aspartic acid receptor structure and function. Physiol. Rev. 1994, 74:723-760.
108. Meador-Woodruff J.H., Healy D.J. Glutamate receptor expression in schizophrenic brain. Brain Res. Brain Res. Rev. 2000, 31:288-294.
109. Meguro H., Mori H., Araki K., Kushiya E., Kutsuwada T., Yamazaki M., Kumanishi T., Arakawa M., Sakimura K., Mishina M. Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature 1992, 357:70-74.
110. Meldrum B.S. Excitotoxicity and selective neuronal loss in epilepsy. Brain Pathol. 1993, 3:405-412.
111. Micu I., Jiang Q., Coderre E., Ridsdale A., Zhang L., Woulfe J., Yin X., Trapp B.D., McRory J.E., Rehak R., Zamponi G.W., Wang W., Stys P.K. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 2006, 439:988-992.
112. Millan M.J. N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology (Berl) 2005, 179:30-53.
113. Mishina M., Mori H., Araki K., Kushiya E., Meguro H., Kutsuwada T., Kashiwabuchi N., Ikeda K., Nagasawa M., Yamazaki M., et al. Molecular and functional diversity of the NMDA receptor channel. Ann. N. Y. Acad. Sci. 1993, 707:136-152.
114. Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron 2003, 40:881-884.
115. Moghaddam B., Jackson M.E. Glutamatergic animal models of schizophrenia. Ann. N. Y. Acad. Sci. 2003, 1003:131-137.
116. Mohn A.R., Gainetdinov R.R., Caron M.G., Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999, 98:427-436.
117. Montgomery J.M., Selcher J.C., Hanson J.E., Madison D.V. Dynamin-dependent NMDAR endocytosis during LTD and its dependence on synaptic state. BMC Neurosci. 2005, 6:48.
118. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994, 12:529-540.
119. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., Seeburg P.H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 1992, 256:1217-1221.
120. Mori H., Mishina M. Structure and function of the NMDA receptor channel. Neuropharmacology 1995, 34:1219-1237.
121. Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N., Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature 1991, 354:31-37.
122. Mueller H.T., Meador-Woodruff J.H. Expression of the NR3A subunit of the NMDA receptor in human fetal brain. Ann. N. Y. Acad. Sci. 2003, 1003:448-451.
123. Mueller H.T., Meador-Woodruff J.H. NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder. Schizophr. Res. 2004, 71:361-370.
124. Mueller H.T., Meador-Woodruff J.H. Distribution of the NMDA receptor NR3A subunit in the adult pig-tail macaque brain. J. Chem. Neuroanat. 2005, 29:157-172.
125. Naassila M., Daoust M. Effect of prenatal and postnatal ethanol exposure on the developmental profile of mRNAs encoding NMDA receptor subunits in rat hippocampus. J. Neurochem. 2002, 80:850-860.
126. Nagerl U.V., Eberhorn N., Cambridge S.B., Bonhoeffer T. Bidirectional activity-dependent morphological plasticity in hippocampal neurons. Neuron 2004, 44:759-767.
127. Nakanishi N., Tu S., Shin Y., Cui J., Kurokawa T., Zhang D., Chen H.S., Tong G., Lipton S.A. Neuroprotection by the NR3A subunit of the NMDA receptor. J. Neurosci. 2009, 29:5260-5265.
128. Newey S.E., Velamoor V., Govek E.E., Van Aelst L. Rho GTPases, dendritic structure, and mental retardation. J. Neurobiol. 2005, 64:58-74.
129. Nilsson A., Duan J., Mo-Boquist L.L., Benedikz E., Sundstrom E. Characterisation of the human NMDA receptor subunit NR3A glycine binding site. Neuropharmacology 2007, 52:1151-1159.
130. Nilsson A., Eriksson M., Muly E.C., Akesson E., Samuelsson E.B., Bogdanovic N., Benedikz E., Sundstrom E. Analysis of NR3A receptor subunits in human native NMDA receptors. Brain Res. 2007, 1186:102-112.
131. Nishi M., Hinds H., Lu H.P., Kawata M., Hayashi Y. Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner. J. Neurosci. 2001, 21:RC185.
132. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 1995, 52:998-1007.
133. Olney J.W., Newcomer J.W., Farber N.B. NMDA receptor hypofunction model of schizophrenia. J. Psychiatr. Res. 1999, 33:523-533.
134. Ozaki M., Sasner M., Yano R., Lu H.S., Buonanno A. Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature 1997, 390:691-694.
135. Paarmann I., Frermann D., Keller B.U., Villmann C., Breitinger H.G., Hollmann M. Kinetics and subunit composition of NMDA receptors in respiratory-related neurons. J. Neurochem. 2005, 93:812-824.
136. Paas Y. The macro- and microarchitectures of the ligand-binding domain of glutamate receptors. Trends Neurosci. 1998, 21:117-125.
137. Paoletti P., Neyton J. NMDA receptor subunits: function and pharmacology. Curr. Opin. Pharmacol. 2007, 7:39-47.
138. Perez-Otano I., Ehlers M.D. Learning from NMDA receptor trafficking: clues to the development and maturation of glutamatergic synapses. Neurosignals 2004, 13:175-189.
139. Perez-Otano I., Lujan R., Tavalin S.J., Plomann M., Modregger J., Liu X.B., Jones E.G., Heinemann S.F., Lo D.C., Ehlers M.D. Endocytosis and synaptic removal of NR3A-containing NMDA receptors by PACSIN1/syndapin1. Nat. Neurosci. 2006, 9:611-621.
140. Perez-Otano I., Schulteis C.T., Contractor A., Lipton S.A., Trimmer J.S., Sucher N.J., Heinemann S.F. Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors. J. Neurosci. 2001, 21:1228-1237.
141. Philpot B.D., Sekhar A.K., Shouval H.Z., Bear M.F. Visual experience and deprivation bidirectionally modify the composition and function of NMDA receptors in visual cortex. Neuron 2001, 29:157-169.
142. Pilowsky L.S., Bressan R.A., Stone J.M., Erlandsson K., Mulligan R.S., Krystal J.H., Ell P.J. First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients. Mol. Psychiatry 2006, 11:118-119.
143. Quinlan E.M., Philpot B.D., Huganir R.L., Bear M.F. Rapid, experience-dependent expression of synaptic NMDA receptors in visual cortex in vivo. Nat. Neurosci. 1999, 2:352-357.
144. Racca C., Stephenson F.A., Streit P., Roberts J.D., Somogyi P. NMDA receptor content of synapses in stratum radiatum of the hippocampal CA1 area. J. Neurosci. 2000, 20:2512-2522.
145. Roberts A.C., Diez-Garcia J., Rodriguiz R.M., Lopez I.P., Lujan R., Martinez-Turrillas R., Pico E., Henson M.A., Bernardo D.R., Jarrett T.M., Clendeninn D.J., Lopez-Mascaraque L., Feng G., Lo D.C., Wesseling J.F., Wetsel W.C., Philpot B.D., Perez-Otano I. Downregulation of NR3A-containing NMDARs is required for synapse maturation and memory consolidation. Neuron 2009, 63:342-356.
146. Rosenmund C., Stern-Bach Y., Stevens C.F. The tetrameric structure of a glutamate receptor channel. Science 1998, 280:1596-1599.
147. Rothman S.M., Olney J.W. Excitotoxicity and the NMDA receptor--still lethal after eight years. Trends Neurosci. 1995, 18:57-58.
148. Rumpel S., Hatt H., Gottmann K. Silent synapses in the developing rat visual cortex: evidence for postsynaptic expression of synaptic plasticity. J. Neurosci. 1998, 18:8863-8874.
149. Salter M.G., Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 2005, 438:1167-1171.
150. Sanchez-Vives M.V., McCormick D.A. Cellular and network mechanisms of rhythmic recurrent activity in neocortex. Nat. Neurosci. 2000, 3:1027-1034.
151. Sans N., Petralia R.S., Wang Y.X., Blahos J., Hell J.W., Wenthold R.J. A developmental change in NMDA receptor-associated proteins at hippocampal synapses. J. Neurosci. 2000, 20:1260-1271.
152. Sasaki Y.F., Rothe T., Premkumar L.S., Das S., Cui J., Talantova M.V., Wong H.K., Gong X., Chan S.F., Zhang D., Nakanishi N., Sucher N.J., Lipton S.A. Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons. J. Neurophysiol. 2002, 87:2052-2063.
153. Sawtell N.B., Frenkel M.Y., Philpot B.D., Nakazawa K., Tonegawa S., Bear M.F. NMDA receptor-dependent ocular dominance plasticity in adult visual cortex. Neuron 2003, 38:977-985.
154. Schorge S., Colquhoun D. Studies of NMDA receptor function and stoichiometry with truncated and tandem subunits. J. Neurosci. 2003, 23:1151-1158.
155. Schuler T., Mesic I., Madry C., Bartholomaus I., Laube B. Formation of NR1/NR2 and NR1/NR3 heterodimers constitutes the initial step in N-methyl-d-aspartate receptor assembly. J. Biol. Chem. 2008, 283:37-46.
156. Scott D.B., Blanpied T.A., Swanson G.T., Zhang C., Ehlers M.D. An NMDA receptor ER retention signal regulated by phosphorylation and alternative splicing. J. Neurosci. 2001, 21:3063-3072.
157. Scott D.B., Michailidis I., Mu Y., Logothetis D., Ehlers M.D. Endocytosis and degradative sorting of NMDA receptors by conserved membrane-proximal signals. J. Neurosci. 2004, 24:7096-7109.
158. Sheng M., Cummings J., Roldan L.A., Jan Y.N., Jan L.Y. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 1994, 368:144-147.
159. Smothers C.T., Woodward J.J. Effect of the NR3 subunit on ethanol inhibition of recombinant NMDA receptors. Brain Res. 2003, 987:117-121.
160. Smothers C.T., Woodward J.J. Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-d-aspartate NR1 and NR3 subunits. J. Pharmacol. Exp. Ther. 2007, 322:739-748.
161. Standley S., Roche K.W., McCallum J., Sans N., Wenthold R.J. PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants. Neuron 2000, 28:887-898.
162. Stefansson H., Steinthorsdottir V., Thorgeirsson T.E., Gulcher J.R., Stefansson K. Neuregulin 1 and schizophrenia. Ann. Med. 2004, 36:62-71.
163. Straub R.E., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., Wormley B., Sadek H., Kadambi B., O'Neill F.A., Walsh D., Kendler K.S. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol. Psychiatry 2002, 7:542-559.
164. Sucher N.J., Akbarian S., Chi C.L., Leclerc C.L., Awobuluyi M., Deitcher D.L., Wu M.K., Yuan J.P., Jones E.G., Lipton S.A. Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain. J. Neurosci. 1995, 15:6509-6520.
165. Sucher N.J., Kohler K., Tenneti L., Wong H.K., Grunder T., Fauser S., Wheeler-Schilling T., Nakanishi N., Lipton S.A., Guenther E. N-methyl-d-aspartate receptor subunit NR3A in the retina: developmental expression, cellular localization, and functional aspects. Invest. Ophthalmol. Vis. Sci. 2003, 44:4451-4456.
166. Sugihara H., Moriyoshi K., Ishii T., Masu M., Nakanishi S. Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing. Biochem. Biophys. Res. Commun. 1992, 185:826-832.
167. Sullivan J.M., Traynelis S.F., Chen H.S., Escobar W., Heinemann S.F., Lipton S.A. Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor. Neuron 1994, 13:929-936.
168. Sun L., Margolis F.L., Shipley M.T., Lidow M.S. Identification of a long variant of mRNA encoding the NR3 subunit of the NMDA receptor: its regional distribution and developmental expression in the rat brain. FEBS Lett. 1998, 441:392-396.
169. Sun L., Shipley M.T., Lidow M.S. Expression of NR1, NR2A-D, and NR3 subunits of the NMDA receptor in the cerebral cortex and olfactory bulb of adult rat. Synapse 2000, 35:212-221.
170. Tamminga C.A. Schizophrenia and glutamatergic transmission. Crit. Rev. Neurobiol. 1998, 12:21-36.
171. Tang Y.P., Shimizu E., Dube G.R., Rampon C., Kerchner G.A., Zhuo M., Liu G., Tsien J.Z. Genetic enhancement of learning and memory in mice. Nature 1999, 401:63-69.
172. Tong G., Takahashi H., Tu S., Shin Y., Talantova M., Zago W., Xia P., Nie Z., Goetz T., Zhang D., Lipton S.A., Nakanishi N. Modulation of NMDA receptor properties and synaptic transmission by the NR3A subunit in mouse hippocampal and cerebrocortical neurons. J. Neurophysiol. 2008, 99:122-132.
173. Tsai G., van Kammen D.P., Chen S., Kelley M.E., Grier A., Coyle J.T. Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia. Biol. Psychiatry 1998, 44:667-674.
174. Tu S., Shin Y., Zago W.M., States B.A., Eroshkin A., Lipton S.A., Tong G.G., Nakanishi N. Takusan: a large gene family that regulates synaptic activity. Neuron 2007, 55:69-85.
175. Ulbrich M.H., Isacoff E.Y. Subunit counting in membrane-bound proteins. Nat. Methods 2007, 4:319-321.
176. Ulbrich M.H., Isacoff E.Y. Rules of engagement for NMDA receptor subunits. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:14163-14168.
177. Ullian E.M., Barkis W.B., Chen S., Diamond J.S., Barres B.A. Invulnerability of retinal ganglion cells to NMDA excitotoxicity. Mol. Cell. Neurosci. 2004, 26:544-557.
178. Wada A., Takahashi H., Lipton S.A., Chen H.S. NR3A modulates the outer vestibule of the " NMDA" receptor channel. J. Neurosci. 2006, 26:13156-13166.
179. Washbourne P., Liu X.B., Jones E.G., McAllister A.K. Cycling of NMDA receptors during trafficking in neurons before synapse formation. J. Neurosci. 2004, 24:8253-8264.
180. Watanabe M., Inoue Y., Sakimura K., Mishina M. Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport 1992, 3:1138-1140.
181. Wee K.S., Zhang Y., Khanna S., Low C.M. Immunolocalization of NMDA receptor subunit NR3B in selected structures in the rat forebrain, cerebellum, and lumbar spinal cord. J. Comp. Neurol. 2008, 509:118-135.
182. Wenk G.L. Neuropathologic changes in Alzheimer's disease: potential targets for treatment. J. Clin. Psychiatry 2006, 67(Suppl. 3):3-7. quiz 23.
183. Wong H.K., Liu X.B., Matos M.F., Chan S.F., Perez-Otano I., Boysen M., Cui J., Nakanishi N., Trimmer J.S., Jones E.G., Lipton S.A., Sucher N.J. Temporal and regional expression of NMDA receptor subunit NR3A in the mammalian brain. J. Comp. Neurol. 2002, 450:303-317.
184. Wu G.-Y., Malinow R., Cline H.T. Maturation of a central glutamatergic synapse. Science 1996, 274:972-976.
185. Yao Y., Harrison C.B., Freddolino P.L., Schulten K., Mayer M.L. Molecular mechanism of ligand recognition by NR3 subtype glutamate receptors. EMBO J. 2008, 27:2158-2170.
186. Yao Y., Mayer M.L. Characterization of a soluble ligand binding domain of the NMDA receptor regulatory subunit NR3A. J. Neurosci. 2006, 26:4559-4566.
187. Yuste R., Bonhoeffer T. Morphological changes in dendritic spines associated with long-term synaptic plasticity. Annu. Rev. Neurosci. 2001, 24:1071-1089.
188. Zeevalk G.D., Nicklas W.J. NMDA receptors, cellular edema, and metabolic stress. Ann. N. Y. Acad. Sci. 1992, 648:368-370.
189. Zhang X.Y., Liu A.P., Ruan D.Y., Liu J. Effect of developmental lead exposure on the expression of specific NMDA receptor subunit mRNAs in the hippocampus of neonatal rats by digoxigenin-labeled in situ hybridization histochemistry. Neurotoxicol. Teratol. 2002, 24:149-160.